AstraZeneca, Bristol-Myers Oppose "Do Over"

Law360, New York (July 10, 2007, 12:00 AM EDT) -- AstraZeneca LP and Bristol-Myers Squibb Co. have asked a judge to reject plaintiffs' request that the court award them an additional year's worth of damages, pointing out that the group's earlier quest to prove the degree of alleged harm had already failed.

On Monday, the pharmaceutical companies fired back at the plaintiffs, arguing that they were attempting to get away with a "do-over" through their reconsideration motion filed last Thursday.

A slew of big-name pharmaceutical companies, including AstraZeneca and Bristol-Myers, stand accused of laying about average...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.